Skip to main content
Nephron is fully inspected and approved by the FDA!
Close

Lexington Ledger: Nephron Corp CEO Lou Kennedy named 2023 honoree of the McNair Conversations on the American South

January 17, 2023

The University of South Carolina College of Arts & Sciences Institute for Southern Studies today announced Nephron Pharmaceuticals Corporation CEO Lou Kennedy as the 2023 honoree of the McNair Conversations on the American South.

As a part of honoring Kennedy, Dr. Smith, Director of the Institute, will interview the business leader live, before an audience at the USC School of Law, Karen J. Williams Courtroom, for a podcast associated with the event on Wednesday, March 1 2023 at 6PM.

“I am grateful to be recognized by the university I love, and I look forward to joining Dr. Smith and audience participants for a wonderful discussion about all of the great progress South Carolina continues to make,” said Kennedy. “Nephron is a source of pride for me, and I employ many lessons I learned growing up in the American South, and at Carolina, every day as a CEO. Sharing this experience is something I cannot wait to do during my discussion with Dr. Smith.”

Read The Full Story Here